(S)-tert-Butyl 3-methyl-5-oxopiperidine-1-carboxylate

Catalog No. :
ACMRUX753
CAS No. :
1601475-89-1
Molecular Formula :
C11H19NO3
Molecular Weight :
213.28

IUPAC Name:tert-butyl (S)-3-methyl-5-oxopiperidine-1-carboxylate

(S)-tert-Butyl 3-methyl-5-oxopiperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$55.00Login to see priceIn stockIn stock
250mg97%$136.00Login to see priceIn stockIn stock
1g97%$533.00Login to see priceIn stockIn stock
5g97%$2212.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-tert-Butyl 3-methyl-5-oxopiperidine-1-carboxylate
IUPAC Nametert-butyl (S)-3-methyl-5-oxopiperidine-1-carboxylate
MDL No.MFCD29472560
Molecular FormulaC11H19NO3
Molecular Weight213.28
SMILESO=C(N1C[C@@H](C)CC(C1)=O)OC(C)(C)C
InChI KeyPIXOEWQIZRMJQU-QMMMGPOBSA-N
Synonym1601475-89-1 | (S)-tert-butyl 3-methyl-5-oxopiperidine-1-carboxylate | tert-butyl (S)-3-methyl-5-oxopiperidine-1-carboxylate | 1-Piperidinecarboxylic acid, 3-methyl-5-oxo-, 1,1-dimethylethyl ester, (3S)- | tert-butyl (3S)-3-methyl-5-oxopiperidine-1-carbox
CAS No.1601475-89-1
PubChem CID119081421

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362

Synthetic Route by SureRoute

1. ACMRUX753 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMDUR493 route compound structure diagram
    ACMDUR4931932597-68-6 In Stock
  2. Then
  3. ACMRUX753 route product structure diagram
    ACMRUX7531601475-89-1 In Stock
Inquiry

2. ACMRUX753 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMRUX753 route product structure diagram
    ACMRUX7531601475-89-1 In Stock
Inquiry

Comments (0)